View in EDS

Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort.

Saved in:
Bibliographic Details
Title: Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort.
Authors: Ho IW; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Hematology Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan., Li CP; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Clinical Skills Training, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Therapeutic and Research Center of Pancreatic Cancer, Taipei Veterans General Hospital, Taipei, Taiwan., Yang SH; National Taiwan University Hospital, Taipei, Taiwan., Wang HT; Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan., Lin CY; Division of Hematology/Oncology, Department of Internal Medicine, Wuri Lin Shin Hospital, Taichung, Taiwan., Su YY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Ho CL; Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan., Chou WC; Department of Hematology and Oncology, Chang Gung Memorial Hospital at Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan., Chiu TJ; Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Shih YH; Division of Medical Oncology, Department of Oncology, Taichung Veterans General Hospital, Taichung, Taiwan., Feng YH; Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan., Chang YS; Keelung Chang Gung Memorial Hospital, Keelung, Taiwan., Hung CC; Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan., Chiu CF; Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan., Bai LY; Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan. Electronic address: 013664@tool.caaumed.org.tw.
Source: Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2026 Apr 11. Date of Electronic Publication: 2026 Apr 11.
Publication Type: Journal Article
Journal Info: Publisher: Formosan Medical Association, Elsevier Country of Publication: Singapore NLM ID: 9214933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0929-6646 (Print) Linking ISSN: 09296646 NLM ISO Abbreviation: J Formos Med Assoc Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41968047
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ho+IW%22">Ho IW</searchLink>; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Hematology Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Li+CP%22">Li CP</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Clinical Skills Training, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Therapeutic and Research Center of Pancreatic Cancer, Taipei Veterans General Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yang+SH%22">Yang SH</searchLink>; National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+HT%22">Wang HT</searchLink>; Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+CY%22">Lin CY</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, Wuri Lin Shin Hospital, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Su+YY%22">Su YY</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ho+CL%22">Ho CL</searchLink>; Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chou+WC%22">Chou WC</searchLink>; Department of Hematology and Oncology, Chang Gung Memorial Hospital at Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chiu+TJ%22">Chiu TJ</searchLink>; Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Shih+YH%22">Shih YH</searchLink>; Division of Medical Oncology, Department of Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Feng+YH%22">Feng YH</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+YS%22">Chang YS</searchLink>; Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hung+CC%22">Hung CC</searchLink>; Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chiu+CF%22">Chiu CF</searchLink>; Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Bai+LY%22">Bai LY</searchLink>; Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan. Electronic address: 013664@tool.caaumed.org.tw.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229214933%22">Journal of the Formosan Medical Association = Taiwan yi zhi</searchLink> [J Formos Med Assoc] 2026 Apr 11. <i>Date of Electronic Publication: </i>2026 Apr 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Formosan+Medical+Association%2C+Elsevier%22">Formosan Medical Association, Elsevier </searchLink><i>Country of Publication: </i>Singapore <i>NLM ID: </i>9214933 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>0929-6646 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209296646%22">09296646 </searchLink><i>NLM ISO Abbreviation: </i>J Formos Med Assoc <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41968047
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jfma.2026.04.039
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ho IW
      – PersonEntity:
          Name:
            NameFull: Li CP
      – PersonEntity:
          Name:
            NameFull: Yang SH
      – PersonEntity:
          Name:
            NameFull: Wang HT
      – PersonEntity:
          Name:
            NameFull: Lin CY
      – PersonEntity:
          Name:
            NameFull: Su YY
      – PersonEntity:
          Name:
            NameFull: Ho CL
      – PersonEntity:
          Name:
            NameFull: Chou WC
      – PersonEntity:
          Name:
            NameFull: Chiu TJ
      – PersonEntity:
          Name:
            NameFull: Shih YH
      – PersonEntity:
          Name:
            NameFull: Feng YH
      – PersonEntity:
          Name:
            NameFull: Chang YS
      – PersonEntity:
          Name:
            NameFull: Hung CC
      – PersonEntity:
          Name:
            NameFull: Chiu CF
      – PersonEntity:
          Name:
            NameFull: Bai LY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 04
              Text: 2026 Apr 11
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 0929-6646
          Titles:
            – TitleFull: Journal of the Formosan Medical Association = Taiwan yi zhi
              Type: main
ResultId 1